GSK plc announced the marketing authorisation of Exdensur (depemokimab) by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA). In the UK, Exdensur is now approved in two indications: ...
AstraZeneca’s Saphnelo (anifrolumab) has been approved in the European Union (EU) for subcutaneous self-administration as a pre-filled pen for adult patients with systemic lupus erythematosus (SLE) on ...
ICMR reopens the call for EoI for development of mAbs against Nipah virus due to inadequate responses: Shardul Nautiyal, Mumbai Wednesday, December 17, 2025, 08:00 Hrs [IST] Due t ...
IPC 2025 to accelerate HR strengthening in life sciences as technology & talent converge: Nandita Vijayasimha, Bengaluru Wednesday, December 17, 2025, 08:00 Hrs [IST] As the life ...
AKCDA seeks DCGI’s intervention in fake drug scandal at Kerala's discount pharmacies: Peethaambaran Kunnathoor, Chennai Wednesday, December 17, 2025, 08:00 Hrs [IST] The All Ker ...
Smart manufacturing & advanced pharmaceuticals to shape the future by 2030: Kaushik Desai: Nandita Vijayasimha Bengaluru Wednesday, December 17, 2025, 08:00 Hrs [IST] By 2030, the ...
The Karnataka Pharma Retailers & Distributors Organization (KPRDO) has recently expressed concern over the partnership between Swiggy Instamart and PharmEasy for a rapid drug delivery model in ...
AP pharmacists raise alarm over council election irregularities, petition filed in HC: Peethaambaran Kunnathoor, Chennai Wednesday, December 17, 2025, 08:00 Hrs [IST] Registered p ...
Reshaping talent acquisition in pharma through recruitment process outsourcing Pharmaceutical companies face growing pressure to meet commercial launch timelines, often while hiring across unfamiliar ...
CMRI launches Eastern India’s first comprehensive lung nodule evaluation & advanced management clinic: Our Bureau, Bengaluru ...
Bristol Myers Squibb, one of the world’s largest biopharmaceutical companies, and Accenture, a global professional services ...
US FDA clears Minghui Pharma’s IND application to begin global phase ? trials of MHB018A, a subcutaneous single-domain IGF-1R antibody, in thyroid eye disease: Shanghai Tuesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback